JP Morgan Downgrades Xylem to Underweight, Lowers Price Target to $90

Benzinga · 2d ago
JP Morgan analyst Michael Fairbanks downgrades Xylem (NYSE:XYL) from Neutral to Underweight and lowers the price target from $118 to $90.